HZNP News and Press, Horizon Therapeutics Public Limited Company From 11/30/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Horizon Therapeutics (NASDAQ: HZNP ) stock is rising higher on Wednesday following reports that the company is considering a buyout . According to a news release from the c...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday! Moving stocks are a restructuring plan, public securities offerings, earnin...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT OF A POSSIBLE OFFER UNDER RULE 2.4 OF THE...

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has completed enrollment of its Phase 3 clinical trial (OPTIC-J) in Japan evaluating TEPEZZA for the treatment of active Thyroid Eye Disease (TED). TED is a serious, progressive and potentially vision-threatening rare a...

Horizon Therapeutics plc today announced that it has entered a multi-year scientific collaboration with Johns Hopkins University School of Medicine to identify new disease targets and develop therapies for patients with serious autoimmune and inflammatory conditions. The initial foc...

Paulson & Co., the fund headed by John Paulson took a new stake in content platform Rumble ( NASDAQ: RUM ) with a 300K-share holding, and exited the SPDR Gold Trust ETF ( NYSEARCA: GLD ), DiDi Global ( OTCPK:DIDIY ), and Exxon Mobil ( NYSE: XOM ) in the...

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conferences in November: Stifel 2022 Healthcare Conference Date: Tuesday, Nov. 15, 2022 Presentation Time: 1:15 p.m. ET Location: New York, NY P...

-- Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 -- -- Imaging analyses visualize impact of KRYSTEXXA with methotrexate on reducing uric acid de...

-- MIRROR randomized controlled trial data to be presented during Kidney Week 2022 show consistent kidney function, eGFR levels, for people receiving KRYSTEXXA with methotrexate throughout the treatment period -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced new da...

Horizon Therapeutics ( NASDAQ: HZNP ) ticked up 0.3%, quickly paring an earlier decline, on speculation that the company may be the target of an activist after a 13-F filing. Barclays added 3.56 million shares in 3Q, up from 288K in the prior quarter, Dealreporter ...